Immunodiagnostic reagent optimized for latent tuberculosis testing in general hospital settings. This test provides rapid and reliable detection of latent TB infection using advanced IGRA technology.
Manufactured by
INVITROS CO., LTD
South Korea
Invitros is an in-vitro diagnostic medical device manufacturing company, specializing in diagnostic reagents for allergies, tuberculosis, and respiratory diseases. Leveraging our advanced technology, we contribute to the early diagnosis of diseases, quick recovery of health, and well-being. With more than two decades of experience and expertise in the field, we remain committed to improving healthcare outcomes globally.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
bioactiva diagnostica GmbH
Germany · 6 relevant products
Rayto Life and Analytical Sciences Co., Ltd.
China · 1 relevant product
78 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →18 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 103 closest product alternatives
guangzhou biotron technolongy co.,ltd · China
Interferon-gamma release assay for detection of tuberculosis infection and exposure assessment in clinical and occupational health settings.
bioactiva diagnostica GmbH · Germany
INTRAY GC is an interferon-gamma release assay (IGRA) for detecting latent tuberculosis infection (LTBI) and active TB disease. The assay identifies persistent immune responses to Mycobacterium tuberculosis antigens, enabling accurate differentiation between TB infection states. It serves as an alternative to tuberculin skin testing and QuantiFERON assays for TB screening and diagnosis.
bioactiva diagnostica GmbH · Germany
An interferon-gamma release assay (IGRA) for detection of latent tuberculosis infection (LTBI) and active tuberculosis. This novel assay demonstrates high accuracy in differentiating between latent and active Mycobacterium tuberculosis infection compared to established reference methods.
100 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products